Compugen

-$0.12 (-1.50%) Today
-$0.04 (-0.51%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Compugen and other stocks, options, and ETFs commission-free!

About CGEN

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases.

CEO
Anat Cohen-Dayag
Employees
68
Headquarters
Holon, Tel Aviv
Founded
1993

CGEN Key Statistics

Market Cap
631.78M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.30M
High Today
$8.08
Low Today
$7.68
Open Price
$7.86
Volume
832.02K
52 Week High
$19.90
52 Week Low
$6.74

CGEN Earnings

-$0.13
-$0.11
-$0.10
-$0.08
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.13 per share
Actual
-$0.12 per share
Replay Earnings Call

You May Also Like

TWND=
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure